Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer

NCT00566540 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Recruitment problems with study

Conditions

Head and Neck Cancer

Interventions

DRUG: Cisplatin
DRUG: Paclitaxel
RADIATION: Intensity-Modulated Radiation Therapy (IMRT) External Beam Radiation
PROCEDURE: Triple endoscopy and biopsy

Sponsor

Ohio State University Comprehensive Cancer Center